Press Releases

VANCOUVER, British Columbia, Oct. 3, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces it has received a Provisional Nursery License for Core Isogenics Inc.Core Isogenics Inc. received a yearly renewable Provisional Cultivation License issued

SAN DIEGO, Oct. 3, 2019 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced a restructuring to focus its resources on the clinical develop

LOS ANGELES, Oct. 3, 2019 /PRNewswire/ -- Winged, the first CBD product line formulated exclusively for women, announced today its pledge to donate $25,000 this year

TUCSON, Ariz., Oct. 3, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. today announced presentation of full data from three outcome studies at IDWeek™ 2019. The full data being presented build upon the high-level findings that were first reported in the Company's September 18, 2019 press release.

YOQNEAM, Israel, Oct. 3, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, announced that it has completed the establishment of two new subsidiaries in the Asia Pacific region - InMode India, located in Delhi, and InMode Aust

AHMEDABAD, India, Oct. 3, 2019 /PRNewswire/ -- Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that Saroglitazar Magnesium has achieved the primary end-points in the EVIDENCES IV trial in patients with NAFLD and NASH.The EVIDENCES IV NASH trial was a randomized, double-blind, placebo-controlled study that enrolled 106 pat

DUBLIN, Oct. 3, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced the relaunch of the AB rated generic equivalent of Transderm Scop® (scopolamine 1.5 mg). Annual market sales of Transderm Scop® and therapeutic equivalents for the 12 months ending August 2019 were approximately

BOSTON, Oct. 3, 2019 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts ("Blue Cross") today announced that it will offer

HOUSTON, Oct. 3, 2019 /PRNewswire/ -- Soliton, Inc., (NASDAQ: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that their article entitled, "Increased Tattoo Fa

ST. LOUIS, Oct. 3, 2019 /PRNewswire/ -- BacterioScan, Inc., a St. Louis-based rapid diagnostic device company, has been selected to present advances on its in vitro diagnostic platform at IDWeek 2019. The conference is the annual meeting of the Infectious Diseases Society of America in Washington, DC